Authors: DEVOGELAER JP BROLL H CORREAROTTER R CUMMING DC DEDEUXCHAISNES CN GEUSENS P HOSKING D JAEGER P KAUFMAN JM LEITE M LEON J LIBERMAN U MENKES CJ MEUNIER PJ REID I RODRIGUEZ J ROMANOWICZ A SEEMAN E VERMEULEN A HIRSCH LJ LOMBARDI A PLEZIA K SANTORA AC YATES AJ YUAN W

Citation: Jp. Devogelaer et al., ORAL ALENDRONATE INDUCES PROGRESSIVE INCREASES IN BONE MASS OF THE SPINE, HIP, AND TOTAL-BODY OVER 3 YEARS IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS, Bone, 18(2), 1996, pp. 141-150

Authors: HIRSCH L WATTS N MCILWAIN H RODRIQUEZ J ROMANOWICZ A DAIFOTIS A KHER U SANTORA A

Citation: L. Hirsch et al., EFFICACY OF ALENDRONATE TO INCREASE BMD IS SIMILAR IRRESPECTIVE OF BASE-LINE BONE TURNOVER, BMD AND AGE, Journal of bone and mineral research, 10, 1995, pp. 350-350

Authors: BANKHURST A MCILWAIN H EMKEY R YOOD R ROMANOWICZ A PASSERI M QUAN H SHAPIRO D DAIFOTIS A KARPF D

Citation: A. Bankhurst et al., 3-YEAR TREATMENT WITH ALENDRONATE PREVENTS FRACTURES IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS, Arthritis and rheumatism, 38(9), 1995, pp. 1238-1238